Avadel Pharmaceuticals PLC (AVDL)
15.48
-0.27
(-1.71%)
USD |
NASDAQ |
May 28, 16:00
15.48
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Cash and Short Term Investments (Quarterly): 88.79M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 88.79M |
December 31, 2023 | 105.11M |
September 30, 2023 | 153.18M |
June 30, 2023 | 160.51M |
March 31, 2023 | 100.92M |
December 31, 2022 | 96.50M |
September 30, 2022 | 106.48M |
June 30, 2022 | 104.12M |
March 31, 2022 | 123.48M |
December 31, 2021 | 157.22M |
September 30, 2021 | 181.09M |
June 30, 2021 | 202.84M |
March 31, 2021 | 204.98M |
December 31, 2020 | 221.40M |
September 30, 2020 | 231.58M |
June 30, 2020 | 238.55M |
March 31, 2020 | 113.48M |
December 31, 2019 | 64.16M |
September 30, 2019 | 72.45M |
June 30, 2019 | 79.26M |
March 31, 2019 | 79.85M |
December 31, 2018 | 99.92M |
September 30, 2018 | 125.26M |
June 30, 2018 | 147.11M |
March 31, 2018 | 198.18M |
Date | Value |
---|---|
December 31, 2017 | 94.08M |
September 30, 2017 | 115.61M |
June 30, 2017 | 173.80M |
March 31, 2017 | 179.21M |
December 31, 2016 | 154.20M |
September 30, 2016 | 149.67M |
June 30, 2016 | 154.86M |
March 31, 2016 | 159.95M |
December 31, 2015 | 144.80M |
June 30, 2015 | 116.12M |
March 31, 2015 | 113.17M |
December 31, 2014 | 92.83M |
September 30, 2014 | 76.50M |
June 30, 2014 | 77.86M |
March 31, 2014 | 83.52M |
December 31, 2013 | 7.037M |
September 30, 2013 | 9.28M |
June 30, 2013 | 9.723M |
March 31, 2013 | 15.37M |
December 31, 2012 | 9.155M |
June 30, 2012 | 20.44M |
March 31, 2012 | 22.72M |
December 31, 2011 | 24.49M |
September 30, 2011 | 29.46M |
June 30, 2011 | 32.98M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
64.16M
Minimum
Dec 2019
238.55M
Maximum
Jun 2020
140.31M
Average
118.48M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Trinity Biotech PLC | 3.691M |
Amarin Corp PLC | 308.18M |
Medtronic PLC | 8.005B |
Akari Therapeutics PLC | 1.31M |
Biodexa Pharmaceuticals Plc | 7.606M |